February 22, 2011 - 10:30 AM

EU/US Harmonization Efforts: Assessing the Impact on the Global Pharmaceutical Industry

This event has already occurred.

The pharmaceutical, biotech and medical device industries are increasingly facing a more challenging regulatory and enforcement landscape throughout Europe. This intensive, multi-day educational and training program addresses the myriad of legal, regulatory and compliance issues faced by pharmaceutical, biotech and medical device manufacturers doing business in Europe.

Program Details:

International faculty include high-level government regulators, health and legal scholars, in-house and outside counsel, consultants and industry compliance professionals.

Session topics include third-party risk, European healthcare reimbursement and delivery programs, anti-trust/competition law, development, advertising and promotion of drugs and devices, fraud investigations and the European enforcement landscape, OECD and other anti-corruption standards, industry codes, privacy laws and much more.

Attendees will receive a joint certificate from Seton Hall Law School and Sciences Po upon completion of the Program.

For more information, visit Seton Hall Law.